APA (7th ed.) Citation

AK, E., DS, E., AH, A., M, A., & M, E. (2023). An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications. Medicinal research reviews, 43(2), 343. https://doi.org/10.1002/med.21928

Chicago Style (17th ed.) Citation

AK, ElHady, El-Gamil DS, Abadi AH, Abdel-Halim M, and Engel M. "An Overview of Cdc2-like Kinase 1 (Clk1) Inhibitors and Their Therapeutic Indications." Medicinal Research Reviews 43, no. 2 (2023): 343. https://doi.org/10.1002/med.21928.

MLA (9th ed.) Citation

AK, ElHady, et al. "An Overview of Cdc2-like Kinase 1 (Clk1) Inhibitors and Their Therapeutic Indications." Medicinal Research Reviews, vol. 43, no. 2, 2023, p. 343, https://doi.org/10.1002/med.21928.